Regulating the cancer-inducing potential of non-steroidal anti-inflammatory drugs: Some lessons from the 1970s and 1980s-Reference-Cited by-同舟云学术

Regulating the cancer-inducing potential of non-steroidal anti-inflammatory drugs: Some lessons from the 1970s and 1980s

Published:1998-01 Issue:1 Volume:46 Page:39-51
ISSN:0277-9536
Container-title:Social Science & Medicine
language:en
Short-container-title:Social Science & Medicine

Author:

Abraham John

Publisher

Elsevier BV

Subject

History and Philosophy of Science,Health(social science)

Reference80 articles.

1. Guidelines for Preclinical and Clinical Testing of New Medicinal Products Part I—Laboratory Investigations;Association of the British Pharmaceutical Industry (ABPI),1977

2. Experimental methods used in determining chronic toxicity: critical review;Barnes;Pharmacological Reviews,1954

3. Is the clinical trial evidence about new drugs statistically adequate?;Bland;British Journal of Clinical Pharmacology,1985

4. Problem Drugs;Chetley,1995

5. The Health Conspiracy;Collier,1989

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Science, politics, and health in the brave new world of pharmaceutical carcinogenic risk assessment: Technical progress or cycle of regulatory capture?;Social Science & Medicine;2012-10

2. The emergence of the genetically engineered animal models in carcinogenic risk assessment of pharmaceuticals: a case study of process innovation;New Genetics and Society;2012-05-16

3. The Neoliberal Regulatory State, Industry Interests, and the Ideological Penetration of Scientific Knowledge;Science, Technology, & Human Values;2011-11-24

4. Power, expertise and the limits of representative democracy: genetics as scientific progress or political legitimation in carcinogenic risk assessment of pharmaceuticals?;Journal of Community Genetics;2011-07-20

5. Genotoxicity and carcinogenicity studies of analgesics, anti-inflammatory drugs and antipyretics;Pharmacological Research;2009-07